GlaxoSmithKline (GSK) has confirmed that CEO Emma Walmsley will step down from her position, effective immediately. Chief Commercial Officer Luke Miels will succeed her...
BioNTech has reached a settlement in a three-year patent dispute involving mRNA technology with GlaxoSmithKline (GSK) and CureVac. As part of this agreement, both...